Sri Lanka, Dec. 21 -- The Indian pharmaceutical company Maan Pharmaceutical (Pvt) Ltd., has informed Sri Lanka's Ministry of Health that it is willing to bear the full cost of testing the withdrawn batches of the Ondansetron injection at an internationally recognised laboratory.

In a letter addressed to the Ministry, the company requested that the relevant batches be referred for independent testing and stated that ensuring the injection samples were stored under proper conditions prior to testing is the responsibility of the Sri Lankan health authorities.

The National Medicines Regulatory Authority (NMRA) on December 13 ordered the immediate withdrawal of four batches of the Ondansetron injection manufactured by Maan Pharmaceutical fro...